89 top medical experts on Immunoproliferative Small Intestinal Disease across 10 countries and 1 U.S. states, including 12 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Immunoproliferative Small Intestinal Disease: A condition that is caused by hyperplasia of lymphocytes in the small intestine (intestine, small) and the mesenteric lymph nodes. These lymphocytes produce an anomalous alpha heavy chain protein. Generally, these ipsid patients have either concurrent lymphoma or develop lymphoma within a few years. The disease was first described in the Mediterranean region and is characterized by malabsorption; weight loss; diarrhea; and steatorrhea.
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Broader Categories (#Experts): Lymphoma (3,090), Heavy Chain Disease (297), Intestinal Neoplasms (2,624), Lymphoproliferative Disorders (2,703).
  4. Synonyms: IgA Type Heavy Chain Disease,  IPSID,  Mediterranean Lymphoma,  alpha-Chain Disease


  

        

                    


    Computing Expert Listing ...

);